Yipin Pharmaceutical

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Yipin Pharmaceutical - overview

Established

2013

Location

Shijiazhuang, Hebei, China

Primary Industry

Pharmaceuticals

About

Based in Hebei, China and established in 2013, Hebei Yipin Pharmaceutical Co. , Ltd. , dba Yipin Pharmaceutical, is a high-tech pharmaceutical enterprise integrating the R&D, production, and sales of general anesthetics and their raw materials. The company's predecessor was Hebei Provincial Institute of Pharmaceutical Research with its core R&D team member originating from the former experimental pharmaceutical plant of the institute.


In 2019, the company established its first R&D subsidiary in Hebei. In September 2026, Yipin Pharmaceutical closed a round of venture funding led by Shanghai Shifeng Xinhui Venture Capital Management with participation from Beijing Qijian Private Fund Management Co. , Ltd. Yipin Pharmaceutical focuses on inhalational general anesthetics and their active pharmaceutical ingredients (APIs) with main products including sevoflurane for inhalation, ketoisoleucine calcium, ropivacaine hydrochloride injection, lidocaine hydrochloride injection, etc.


The company generates revenue from selling general anesthetics and their APIs and other pharmaceutical products. The company will primarily use the funding led by Shanghai Shifeng Xinhui Venture Capital Management for product development and capacity expansion.


Current Investors

Shanghai Shifeng Xinhui Venture Capital Management

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development, Pharmaceuticals

Website

www.hbypzy.com/gyyp

Verticals

HealthTech, Manufacturing

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Yipin Pharmaceutical - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Unspecified RoundCompletedYipin Pharmaceutical-

Displaying 1 - 1 of 1

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.